CME Group MRAN 536: Documentation of Customer Orders and Submission of Suspense Accounts on CME Globex
Effective on October 1, 2018, and pending all relevant CFTC regulatory review periods, this Market Regulation Advisory Notice will supersede CME Group Market Regulation Advisory Notice RA1605-5R from August 19, 2016.
This Advisory Notice sets forth the circumstances under which a suspense account may be submitted on orders entered into CME Globex (“Globex”) and the requirements attendant to proper documentation of such orders. For purposes of this Advisory Notice, a suspense account means a temporary holding account that is submitted at the time of order entry into Globex but prior to the allocation of the executions to the specific accounts on a carrying Clearing Member Firm’s books. With the exception of the section concerning bunched Request for Cross (“RFC”) orders, which is currently in effect, the remainder of this Advisory Notice will become effective on October 1, 2018.
The text of Rule 536.B. (“Globex Order Entry”) and Rule 536.C. (“Bunched Orders and Orders Eligible for Post Execution Allocation”) which are, in part, applicable to the use of suspense accounts, begins on page 5. A Frequently Asked Questions (“FAQ”) section begins on page 8.
Affected parties are strongly urged to review their current usage of suspense accounts and implement any necessary changes prior to the October 1, 2018, effective date.
For full details, view MRAN 536 on the CME Group website.
Contact CME Group Market Reg Outreach team with questions: marketreg.outreach@cmegroup.com, +1 312 341 7970.
